Skip to main content
. 2016 Jun 15;147:1415–1421. doi: 10.1007/s00706-016-1780-0

Table 1.

Structures of some drugs contain α-pyrrolidinophenone unit [4]

Name (CAS number; IUPAC name) R1 R2 R3
Alpha-PPP (19134-50-0; (RS)-1-phenyl-2-(1-pyrrolidinyl)-1-propanone) H CH3 H
MPPP (1313393-58-6; (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-propanone) CH3 CH3 H
Pyrovalerone (3563-49-3; (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-pentan-1-one) CH3 C3H7 H
MPBP (1214-15-9; (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-butanone) CH3 C2H5 H
Alpha-PVP (14530-33-7; (RS)-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone H C3H7 H
MDPPP (24698-57-5; (RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone OCH2 O
(R1 R3)
CH3
MDPBP (24622-60-4; (RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone) –O–CH2–O–
(R1–R3)
C2H5
MDPV (687603-66-3; (RS)-1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one) OCH2 O
(R1 R3)
C3H7